Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Harper

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Oncogene|November 11, 2014
Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancerA Mavrou, K Brakspear, M Hamdollah-Zadeh, et al.
American Journal of Physiology. Renal Physiology|March 10, 2006
VEGF-C promotes survival in podocytesR R Foster, S C Satchell, J Seckley, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients--a randomised prospective studyS J Harper, J Moorhouse, K Abrams, et al.
British Journal of Cancer|March 20, 2008
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapyA H R Varey, E S Rennel, Y Qiu, et al.
Neurobiology of Disease|August 25, 2014
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesiaR P Hulse, N Beazley-Long, J Hua, et al.
Plant Disease|August 26, 2020
Economic Studies Reinforce Efforts to Safeguard Specialty Crops in the United StatesM Fuchs, C V Almeyda, M Al Rwahnih, et al.
Plant Disease|January 2, 2025
Streamlining Global Germplasm Exchange: Integrating Scientific Rigor and Common Sense to Exclude Phantom Agents from RegulationI E Tzanetakis, V Aknadibossian, J Špak, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Oncogene|November 11, 2014
Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancerA Mavrou, K Brakspear, M Hamdollah-Zadeh, et al.
American Journal of Physiology. Renal Physiology|March 10, 2006
VEGF-C promotes survival in podocytesR R Foster, S C Satchell, J Seckley, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients--a randomised prospective studyS J Harper, J Moorhouse, K Abrams, et al.
British Journal of Cancer|March 20, 2008
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapyA H R Varey, E S Rennel, Y Qiu, et al.
Neurobiology of Disease|August 25, 2014
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesiaR P Hulse, N Beazley-Long, J Hua, et al.
Plant Disease|August 26, 2020
Economic Studies Reinforce Efforts to Safeguard Specialty Crops in the United StatesM Fuchs, C V Almeyda, M Al Rwahnih, et al.
Plant Disease|January 2, 2025
Streamlining Global Germplasm Exchange: Integrating Scientific Rigor and Common Sense to Exclude Phantom Agents from RegulationI E Tzanetakis, V Aknadibossian, J Špak, et al.
Pageof 10